mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.03 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.03 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |